Prostate Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Preliminary, Confirmatory (PCA3, Trans-rectal Ultrasound, Biopsy)), By Region, And Segment Forecasts, 2020 - 2027

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources & Third Party Perspectives
1.3.4 Primary Research
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Prostate Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration And Growth Prospect Mapping
3.2.1 User Perspective Analysis
3.2.1.1 Consumer Behavior Analysis
3.3 Regulatory Framework
3.3.1 Reimbursement Framework
3.3.2 Standards And Compliances
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing Prevalence Of Prostate Cancer
3.4.1.2 Increasing Government Initiatives
3.4.1.3 Technological Advancements
3.4.2 Market Restraint Analysis
3.4.2.1 High Cost Of Diagnosis
3.4.3 Market Opportunities Analysis
3.4.4 Market Challenges Analysis
3.5 Prostate Cancer Diagnostics Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 Pestel Analysis
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 Major Deals And Strategic Alliances Analysis
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
Chapter 4 Prostate Cancer Diagnostics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.2.1 List Of Key Distributors And Channel Partners
4.2.2 Key Company Market Share Analysis, 2019
4.3 Public Companies
4.3.1公司市场地位分析
4.4 Private Companies
4.4.1 List Of Key Emerging Companies
4.4.2 Regional Network Map
4.4.3 Company Market Position Analysis
Chapter 5 Prostate Cancer Diagnostics Market: Test Type Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Test Type Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Prostate Cancer Diagnostics Market, by Test Type, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.6 Preliminary Tests
5.6.1 Preliminary Tests Market, 2016 To 2027 (USD Million)
5.7 Confirmatory Tests
5.7.1 Confirmatory Tests Market, 2016 To 2027 (USD Million)
5.7.1.1 Pca3 Test
5.7.1.1.1 Pca3 Test Market Size & Forecasts, 2016 To 2027 (USD Million)
5.7.1.2 Trans-Rectal Ultrasound
5.7.1.2.1 Trans-Rectal Ultrasound Market Size & Forecasts, 2016 To 2027 (USD Million)
5.7.1.3 Biopsy
5.7.1.3.1 Biopsy Market Size & Forecasts, 2016 To 2027 (USD Million)
Chapter 6 Prostate Cancer Diagnostics Market: Regional Estimates & Trend Analysis
6.1 Regional Market Snapshot
6.2 Market Share Analysis by Country, 2019
6.2.1 North America
6.2.1.1 U.S.
6.2.1.2 Canada
6.2.2 Europe
6.2.2.1 U.K.
6.2.2.2 Germany
6.2.2.3 Spain
6.2.2.4 France
6.2.2.5 Italy
6.2.2.6 Russia
6.2.3 Latin America
6.2.3.1 Brazil
6.2.3.2 Mexico
6.2.3.3 Argentina
6.2.4 Asia Pacific
6.2.4.1 Japan
6.2.4.2 China
6.2.4.3 India
6.2.4.4 South Korea
6.2.4.5 Australia
6.2.4.6 Singapore
6.2.5 Middle East & Africa
6.2.5.1 South Africa
6.2.5.2 Saudi Arabia
6.2.5.3 Uae
6.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
6.3.1 North America
6.3.2 Europe
6.3.3 Latin America
6.3.4 Asia Pacific
6.3.5 Middle East & Africa
6.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
6.4.1 North America
6.4.1.1 Market Size, & Forecasts And Trend Analysis, 2016 To 2027 (USD Million)
6.4.1.2 U.S.
6.4.1.2.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.1.3 Canada
6.4.1.3.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2 Europe
6.4.2.1 Market Size, & Forecasts And Trend Analysis, 2016 To 2027 (USD Million)
6.4.2.2 U.K.
6.4.2.2.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2.3 Germany
6.4.2.3.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2.4 France
6.4.2.4.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2.5 Italy
6.4.2.5.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2.6 Spain
6.4.2.6.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.2.7 Russia
6.4.2.7.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3 Asia Pacific
6.4.3.1 Market Size, & Forecasts And Trend Analysis, 2016 To 2027 (USD Million)
6.4.3.2 Japan
6.4.3.2.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3.3 China
6.4.3.3.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3.4 India
6.4.3.4.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3.5 South Korea
6.4.3.5.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3.6 Australia
6.4.3.6.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.3.7 Singapore
6.4.3.7.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.4 Latin America
6.4.4.1 Market Size, & Forecasts And Trend Analysis, 2016 To 2027 (USD Million)
6.4.4.2 Brazil
6.4.4.2.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.4.3 Mexico
6.4.4.3.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.4.4 Argentina
6.4.4.4.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.5 Middle East & Africa
6.4.5.1 Market Size, & Forecasts And Trend Analysis, 2016 To 2027 (USD Million)
6.4.5.2 South Africa
6.4.5.2.1 Market Size & Forecasts And Trend Analysis, By Test Type, 2016 To 2027 (USD Million)
6.4.5.3 Saudi Arabia
6.4.5.3.1 Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2027 (USD Million)
6.4.5.4阿联酋
6.4.5.4.1 Market Size & Forecasts and Trend Analysis, By Test Type, 2016 to 2027 (USD Million)
Chapter 7 Company Profiles
7.1 Company Profiles
7.1.1 MDXHEALTH
7.1.1.1 Company overview
7.1.1.2 Financial Performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 3D SIGNATURES
7.1.2.1 Company overview
7.1.2.2 Financial Performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 GENOMIC HEALTH
7.1.3.1 Company overview
7.1.3.2 Financial Performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4雅培
7.1.4.1 Company overview
7.1.4.2 Financial Performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 OPKO HEALTH, INC.
7.1.5.1 Company overview
7.1.5.2 Financial Performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 SIEMENS HEALTHCARE GMBH
7.1.6.1 Company overview
7.1.6.2 Financial Performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 DIASORIN S.P.A.
7.1.7.1 Company overview
7.1.7.2 Financial Performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 BIOMÉRIEUX SA
7.1.8.1 Company overview
7.1.8.2 Financial Performance
7.1.8.3 Product benchmarking
7.1.8.4 Strategic initiatives
7.1.9 F. HOFFMAN LA ROCHE LTD.
7.1.9.1 Company overview
7.1.9.2 Financial Performance
7.1.9.3 Product benchmarking
7.1.9.4 Strategic initiatives
7.1.10 BECKMAN COULTER, INC.
7.1.10.1 Company overview
7.1.10.2 Financial Performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 MYRIAD GENETIC, INC.
7.1.11.1 Company overview
7.1.11.2 Financial Performance
7.1.11.3 Product benchmarking
7.1.11.4 Strategic initiatives

List of Tables

表1List of key distributors and channel partners
Table 2 List of key emerging companies’/product disruptors/innovators
Table 3 North America Prostate Cancer Diagnostics Market, by countries, 2016 - 2027 (USD Million)
Table 4 North America Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 5 U.S. Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 6 Canada Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 7 Europe Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 8 U.K. Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 9 Germany Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表10 France Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表11 Italy Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表12 Spain Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表13 Russia Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表14 Asia Pacific Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表15 Japan Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表16 China Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表17 India Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表18 South Korea Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
表19 Australia Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 20 Singapore Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 21 Latin America Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 22 Brazil Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 23 Mexico Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 24 Argentina Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 25 MEA Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 26 South Africa Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 27 Saudi Arabia Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)
Table 28 UAE Prostate Cancer Diagnostics Market, by test type, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Prostate Cancer Diagnostics Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 Prostate Cancer Diagnostics Market Snapshot (2019)
Fig. 8 Prostate Cancer Diagnostics Market: Segment Snapshot (2019)
图9 Insigh竞争ts (2019)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
图14前列腺癌诊断市场驱动Impact
Fig. 15 Prostate Cancer Diagnostics Market Restraint Impact
Fig. 16 Prostate Cancer Diagnostics Market Opportunities Impact
Fig. 17 Prostate Cancer Diagnostics Market Challenges Impact
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 20 Strategic alliance analysis
Fig. 21 Recent developments & impact analysis, by key market participants
Fig. 22 Key company market share analysis, 2019
Fig. 23 Company market share/ranking, by region
Fig. 24 Company market position analysis
Fig. 25 Product market share analysis, 2019 & 2027
Fig. 26 Segment dashboard
Fig. 27 Global Prostate Cancer Diagnostics Market, by Test Type, 2016 - 2027 (USD Million)
Fig. 28 Global Confirmatory Tests Market, 2016 - 2027 (USD Million)
Fig. 29 Global PCA3Test Market, 2016 - 2027 (USD Million)
Fig. 30 Global Trans-rectal Ultrasound Market, 2016 - 2027 (USD Million)
Fig. 31 Global Biopsy Market, 2016 - 2027 (USD Million)
Fig. 32 Prostate Cancer Diagnostics Market Snapshot
Fig. 33 North America Prostate Cancer Diagnostics Market Share Analysis by country, 2019
Fig. 34 Europe Prostate Cancer Diagnostics Market Share Analysis by country, 2019
Fig. 35 Asia Pacific Prostate Cancer Diagnostics Market Share Analysis by country, 2019
Fig. 36 Latin America Prostate Cancer Diagnostics Market Share Analysis by country, 2019
Fig. 37 Middle East and Africa Prostate Cancer Diagnostics Market Share Analysis by country, 2019
Fig. 38 North America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 39 Europe SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 40 Asia Pacific SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 41 Latin America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 42 Middle East and Africa SWOT Analysis, by factor (political & legal, economic and technological)